Print

Print


Dear Allstat,

 

CONTRACT - Early Phase Specialist - Switzerland

 

SEC require an experienced Biostatistician with expertise in Phase I/IIa and
Pharmacokinetic data analysis to join our client, a leading pharmaceutical
organisation, on site at there Basel office. This is a 6 month, extendable
contract opportunity.

 

The role will see you leading activities on early phase studies and there
will be a reasonable amount of SAS work in the role

 

You will have an MSc or PhD statistics and a minimum of 4 years relevant
experience including Lead Statistician experience. Strong SAS skills are
essential. 

 

Start date: ASAP

Salary/Rate: Excellent. Call for further details

 

Full assistance with relocation will be provided to the successful
candidates.

 

To apply forward your CV to [log in to unmask]
<mailto:[log in to unmask]>  with a short cover note detailing your
availability and rate expectation. Alternatively call Alan on 0207 255 66 00
for a confidential discussion of the post.

 

Alan Brophy

SEC Recruitment, London
Tel:  0207 255 66 00
Fax: 0207 255 66 01
alan.brophy@sec <mailto:[log in to unmask]> pharma.com
 
SEC are an ISO9001:2000 accredited specialist recruitment company working
within the Pharmaceutical, Biotech and CRO industries. If you are interested
to learn about further appointments within Biostatistics or Statistical
Programming across the UK and Mainland Europe contact Alan on 020 7 255 6600
for a confidential discussion.
 
This email is confidential and intended solely for the use of the 
individual to whom it is addressed. Any views or opinions presented are 
solely those of the author and do not represent those of the company from 
which the email was sent. If you are not the intended recipient, be advised 
that you have received this e-mail in error and that any use, dissemination 
forwarding, printing or copying of this e-mail is strictly prohibited. 
While every effort has been made to scan this e-mail, we can not accept any 
responsibility for loss of business or damage caused arising from this
e-mail.